EU and US could reach trade deal this weekend - Reuters
On Monday, Needham reaffirmed its Buy rating and $64.00 price target for Livanova (NASDAQ:LIVN) shares following a recent legal development. The Italian Supreme Court ruled that Livanova is liable for certain obligations, potentially impacting the company’s financials. According to InvestingPro data, analysts maintain a positive outlook with a consensus recommendation of 1.91 (Buy), with price targets ranging from $53 to $80. The stock currently trades near its 52-week low of $36.85, suggesting potential upside opportunity.
Livanova filed an 8-K revealing that the Italian Supreme Court has determined the company can be held liable for SNIA liabilities. However, the court also found that Livanova should not be responsible for approximately $171 million of the payments. As a result, Livanova anticipates recording a liability of around $363 million during the first quarter of 2025, which is less than the approximately $493 million initially disclosed by the company.
As of December 31, 2024, Livanova had $429 million in cash and $295 million in restricted cash. The company believes it has enough cash on hand to cover the new liability. InvestingPro analysis confirms the company’s strong liquidity position, with a current ratio of 2.87 and liquid assets exceeding short-term obligations. The company operates with a moderate debt level, maintaining a healthy debt-to-equity ratio of 0.51. Livanova has consistently excluded interest related to the liability from its adjusted earnings per share (EPS), previously estimating the interest to be $0.11 per quarter or $0.44 annually. This estimate was based on the initial liability of roughly $493 million. However, with the liability now reduced, the incremental interest expense following the payment is expected to decrease to $0.08 per quarter or $0.32 annually.
Needham expects Livanova’s management to revise its annual guidance to reflect the incremental interest expense when it reports its first-quarter 2025 earnings. The Italian liability issue has been known for several years, and the Italian Supreme Court’s ruling was the final step in Livanova’s attempts to avoid payment. Needham believes that the risk of liability was already understood by investors and likely factored into Livanova’s share price. With a market capitalization of $2.13 billion and according to InvestingPro’s Fair Value analysis, the stock appears undervalued at current levels, suggesting the market may have overreacted to the liability concerns. Discover more insights and 10+ additional ProTips about Livanova in the comprehensive Pro Research Report.
In other recent news, LivaNova PLC is set to record a $363 million liability in its first-quarter financials for 2025 due to a court ruling by the Italian Supreme Court. The ruling pertains to environmental liabilities linked to SNIA, LivaNova’s former parent company. Despite this liability, the company has confirmed sufficient resources to cover the costs. Meanwhile, Goldman Sachs has maintained its Buy rating on LivaNova, with a price target of $55, following investor meetings that reinforced confidence in the company’s growth potential. Mizuho (NYSE:MFG) Securities has adjusted its price target for LivaNova shares from $70 to $60, citing mixed fourth-quarter earnings but maintaining an Outperform rating.
Wolfe Research downgraded LivaNova’s stock from ’Outperform’ to ’Peer Perform,’ reflecting a reassessment of the company’s future earnings potential and valuation. The downgrade considers additional costs related to litigation and stock-based compensation. Stifel analysts also reduced their price target for LivaNova to $60 from $72, while maintaining a Buy rating. They noted the company’s mid-single-digit revenue growth and potential catalysts for 2025, including the SNIA litigation outcome and trial data on obstructive sleep apnea.
These developments highlight the ongoing financial and legal challenges facing LivaNova, as well as the mixed reactions from analysts regarding the company’s future prospects. Investors are closely monitoring these factors as they assess the company’s performance and strategic direction.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.